TIDMAMS
RNS Number : 4643X
Advanced Medical Solutions Grp PLC
29 April 2019
29 April 2019
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, announces
that the Trust which manages the Deferred Share Bonus Plan ("DSB")
on behalf of the employees of AMS has purchased ordinary shares of
5 pence each ("Ordinary Shares") on 29 April 2019, at a price of
330p on behalf of Chris Meredith and Eddie Johnson, who are both
Directors and PDMRs, as part of the DSB and, under the terms of the
DSB, these shares will be held in trust on their behalf.
Following these transactions the beneficial ownership of Chris
Meredith and Eddie Johnson are as follows:
Director/PDMR Date purchased Shares purchased Resultant % of issued
holding share capital
Chris Meredith
Chief Executive 29 April
Officer 2019 10,182 1,494,577 0.7%
================ ================= ========== ===============
Eddie Johnson
Chief Financial 29 April
Officer 2019 3,847 59,426 0.028%
================ ================= ========== ===============
Advanced Medical Solutions Group plc further announces that it
was notified on 29 April 2019 that Chris Meredith, who is a
Director and PDMR, following the end of the holding period,
exercised 32,638 options from the Deferred Annual Bonus Plan (DAB).
Mr Meredith elected to receive an additional 369 dividend shares
which were earned during the 3 year holding period under the terms
of the scheme.
Mr Meredith subsequently sold 33,007 Ordinary Shares of 5p each
on 29 April 2019 at a share price of 330p per Ordinary Share. As a
result of these transactions Mr Meredith's beneficial interest in
the Company has not changed.
Overall Holding
PDMR Holding prior Number Dividend Number Sale price Resultant % of issued
to exercise of shares Shares of shares (p) holding share capital
(including exercised received sold
DSB purchase)
Chris Meredith 1,494,577 32,638 369 33,007 330p 1,494,577 0.7%
--------------- ----------- ---------- ----------- ----------- ---------- ---------------
Advanced Medical Solutions Group plc also announces that on 24
April 2019, the Board, following a recommendation from the
Remuneration Committee, granted new share options to the following
Directors under the Advanced Medical Solutions Deferred Annual
Bonus Plan (the '2014 DAB').
This award is in respect of the part of their bonus that the
Directors and PDMRs are compulsorily required to defer for the 2018
financial year. These options vest at the end of three years.
Details of the current DAB holdings of the Directors/PDMRs
following these awards and the exercise of DAB options by Chris
Meredith are shown below:
Director/PDMR Options prior Options granted Options Resultant holding
to grant/exercise exercised
Chris Meredith
Chief Executive
Officer 77,756 12,859 32,638 57,977
=================== ================ =========== ==================
Eddie Johnson
Chief Financial
Officer 20,333 2,209 - 22,542
=================== ================ =========== ==================
Advanced Medical Solutions Group plc further announces that on
24 April 2019, the Board, following a recommendation from the
Remuneration Committee, granted new share options to the following
Directors/PDMRs under the Advanced Medical Solutions Long Term
Incentive Plan (the 'LTIP'). The vesting period of these options is
subject to certain performance criteria over a three year
period.
Director/PDMR Options prior Options granted Resultant holding
to grant
Chris Meredith
Chief Executive
Officer 476,482 182,510 658,992
============== ================ ==================
Eddie Johnson
Chief Financial
Officer 105,739 38,783 144,522
============== ================ ==================
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Purchase of 10,182 Ordinary Shares as part of the
Deferred Share Bonus Plan on 29 April 2019 at a price
of 330p
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 29/04/2019
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Eddie Johnson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Purchase of 3,847 Ordinary Shares as part of the
Deferred Share Bonus Plan on 29 April 2019 at a price
of 330p
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 29/04/2019
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Exercise of 32,638 shares from the Deferred Annual
Bonus Plan
* Award of 369 Dividend Shares from the Deferred Annual
Bonus Plan
* Sale of 33,007 Ordinary Shares of 5p
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
GBP3.300 33,007
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: 33,007
Aggregated price: GBP3.300
---------------------------------------------------------------------
e) Date of the transaction: 29/04/2019
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Chris Meredith
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 182,510 options under the Advanced Medical
Solutions Long Term Incentive Plan on 24 April 2019
* Grant of 12,859 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 24 April 2019
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 24/04/2019
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Eddie Johnson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Director/PDMR
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Advanced Medical Solutions Group plc
---------------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary Shares of 5p
Identification code: GB0004536594
---------------------------------------------------------------------
b) Nature of the transactions:
* Grant of 38,783 options under the Advanced Medical
Solutions Long Term Incentive Plan on 24 April 2019
* Grant of 2,209 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 24 April 2019
---------------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
n/a n/a
----------
---------------------------------------------------------------------
d) Aggregated information: (Relates to those shares sold
only)
Aggregated volume: n/a
Aggregated price: n/a
---------------------------------------------------------------------
e) Date of the transaction: 24/04/2019
---------------------------------------------------------------------
f) Place of the transaction: London Stock Exchange, AIM
Market (XLON)
---------------------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Nicholas AMS@consilium-comms.com
Brown / Olivia Manser
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Patrick Robb / Gary Clarence
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of products
that include tissue adhesives, sutures, biosurgical devices,
internal sealants, silver alginates, alginates and foams, which it
markets under its brands; LiquiBand(R), LiquiBand(R) Fix 8(TM),
RESORBA(R) and ActivHeal(R) as well as supplying under white
label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 630 employees. For
more information, please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBLGDSSDDBGCC
(END) Dow Jones Newswires
April 29, 2019 12:27 ET (16:27 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024